Cadila Pharma commences a nationwide campaign to eliminate rabies from India by 2030!

- Advertisement - (adsbygoogle = window.adsbygoogle || []).push({});

Mumbai, India (CU)_ Cadila Pharmaceuticals, located in Ahmedabad, and New Delhi-based major business organization Confederation of Indian Industry (CII) have joined hands and started a national campaign to eradicate rabies in India by 2030. The drive was launched last week during the 4th CII Life Sciences Conclave in New Delhi. The purpose of the Conclave, which was attended by leading pharma industry executives, senior government officials, and policymakers, was to discuss building a skillful inorganic development strategy for the life sciences sector.

biospectrumindia.com

A number of initiatives for rabies awareness and prevention will be conducted at the national and state levels under the auspices of the government of India in an effort to eradicate rabies from India by 2030. According to Jawed Zia, Chief Executive Officer of Cadila Pharma, “Lack of public awareness and the resultant failure to complete the vaccine regimen are key causes behind rabies deaths.”

dispatchlive.co.za

Rabies causes over 59,000 deaths annually worldwide, of which approximately 20,000, or slightly more than one-third, occur in India alone. Dr Manjul Joshipura, Senior VP, New Product Development & Innovations at Cadila Pharmaceuticals, spoke about rabies prevention and the role of the company in the initiative. He said, “The key issue is not the loss of lives, but the fact that almost all rabies deaths can be prevented through vaccination. The challenge is awareness and failure to complete the lengthy vaccine regimen, which involves multiple visits to the hospital over several weeks. At Cadila Pharmaceuticals, we have been focusing on preventing rabies deaths, and have recently launched ThRabis, the world’s first three-dose rabies vaccine. The Recombinant vaccine has a simpler regime as compared with other vaccines, and is proving to be a game-changer by helping save many lives”.

A Personal Note from the Publisher" Small photo of you, with your signature beneath

A Personal Note from the Publisher

My dear friend, thank you for your time with us today. This site was built for you, the members of the Commonwealth Family, and nothing matters more to me than hearing your voice and feedback.

What did you make of this article? Did it inform you, challenge you, or leave you wanting more?

Please tell me. I read your replies personally and they help shape everything we publish.

With warmest wishes,
Hon. Nirj Deva
Founder and Publisher.

Free, always. We'll never sell your details.

spot_img

Hot this week

TSMC Tightens Chip Manufacturing Rules for Chinese Companies After New US Export Controls

The world’s largest contract chipmaker, Taiwan Semiconductor Manufacturing Co...

Jamaica and the United States Sign Customs Agreement to Bolster Border Security

Jamaica and the United States have signed a new...

The Flight Was Over, But the Danger Wasn’t: Why Two Virgin Australia Pilots Refused to Fly Again

ADELAIDE, AUSTRALIA — 20 NOVEMBER 2026 It is possible for...

Five Arrests, a Mystery Target and Iran’s Explosive Counterclaim: Who Is Behind the Alleged Greece Assassination Plot?

ATHENS — 19 NOVEMBER 2026 Could a supposed assassination plot...
- Advertisement - (adsbygoogle = window.adsbygoogle || []).push({});

Related Articles

- Advertisement -sitaramatravels.comsitaramatravels.com

Popular Categories